Punda, P.; Kumric, M.; Baric Zizic, A.; Sladic, S.; Vuletic, M.; Supe Domic, D.; Vilovic, M.; Rusic, D.; Bozic, J.
Catestatin and Advanced Glycation End-Products: Potential Indicators of Cardiovascular Risk in Hashimoto’s Thyroiditis. Biomolecules 2025, 15, 169.
https://doi.org/10.3390/biom15020169
AMA Style
Punda P, Kumric M, Baric Zizic A, Sladic S, Vuletic M, Supe Domic D, Vilovic M, Rusic D, Bozic J.
Catestatin and Advanced Glycation End-Products: Potential Indicators of Cardiovascular Risk in Hashimoto’s Thyroiditis. Biomolecules. 2025; 15(2):169.
https://doi.org/10.3390/biom15020169
Chicago/Turabian Style
Punda, Petra, Marko Kumric, Ana Baric Zizic, Sanda Sladic, Marko Vuletic, Daniela Supe Domic, Marino Vilovic, Doris Rusic, and Josko Bozic.
2025. "Catestatin and Advanced Glycation End-Products: Potential Indicators of Cardiovascular Risk in Hashimoto’s Thyroiditis" Biomolecules 15, no. 2: 169.
https://doi.org/10.3390/biom15020169
APA Style
Punda, P., Kumric, M., Baric Zizic, A., Sladic, S., Vuletic, M., Supe Domic, D., Vilovic, M., Rusic, D., & Bozic, J.
(2025). Catestatin and Advanced Glycation End-Products: Potential Indicators of Cardiovascular Risk in Hashimoto’s Thyroiditis. Biomolecules, 15(2), 169.
https://doi.org/10.3390/biom15020169
